Literature DB >> 10939499

Spiral CT of the lung in children with malignant extra-thoracic tumors: distribution of benign vs malignant pulmonary nodules.

S Grampp1, A A Bankier, A Zoubek, P Wiesbauer, B Schroth, C B Henk, N Grois, G H Mostbeck.   

Abstract

The purpose of this paper is to clarify the distribution of benign vs malignant pulmonary nodules which are seen on spiral CT in children with malignant extra-thoracic solid tumors. Seventy-four children with known solid, extra-thoracic tumors underwent spiral CT of the chest. According to the initial and follow-up (interval 9.2+/-4.7 months) findings, the children were graded into four groups: I = normal; II = solitary nodule unchanged at follow-up; III = multiple nodules with one or more than one unchanged at follow-up; and IV = solitary or multiple nodules all changed at follow-up. Nodules without change at follow-up were regarded as benign. Forty-nine children did present with normal pulmonary CT exams. In 7 cases solitary pulmonary nodules were found unchanged (group II) at follow-up and in 2 cases (group III) some of the nodules were stationary. Thus, 12% (9 of 74) presented with at least one pulmonary nodule that did not change at follow-up. Solitary nodules (in groups II and IV) with a diameter <5 mm were in 70 % (7 of 10) unchanged at follow-up and regarded as benign. In children with known solid extra-thoracic tumors at initial presentation, 70% of solitary nodules ( <5 mm) may be benign. To avoid overstaging, smaller solitary nodules must not automatically be regarded as metastases.

Entities:  

Mesh:

Year:  2000        PMID: 10939499     DOI: 10.1007/s003300000359

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  12 in total

Review 1.  Management of an incidentally discovered pulmonary nodule.

Authors:  Catherine Beigelman-Aubry; Catherine Hill; Philippe A Grenier
Journal:  Eur Radiol       Date:  2006-10-05       Impact factor: 5.315

Review 2.  Staging of common paediatric tumours.

Authors:  Hervé J Brisse
Journal:  Pediatr Radiol       Date:  2009-06

3.  Thoracoscopic resection of computed tomography-localized lung nodules in children.

Authors:  Lalit Parida; Israel Fernandez-Pineda; John Uffman; Andrew M Davidoff; Robert Gold; Bhaskar N Rao
Journal:  J Pediatr Surg       Date:  2013-04       Impact factor: 2.545

Review 4.  [Benign and malignant pulmonary tumors in childhood].

Authors:  K Kubin; M Hörmann; M Riccabona; P Wiesbauer; S Puig
Journal:  Radiologe       Date:  2003-12       Impact factor: 0.635

Review 5.  Characterization of small pulmonary nodules by CT.

Authors:  Dag Wormanns; Stefan Diederich
Journal:  Eur Radiol       Date:  2004-05-18       Impact factor: 5.315

6.  The probability of malignancy in small pulmonary nodules coexisting with potentially operable lung cancer detected by CT.

Authors:  Yue Yuan; Tsuneo Matsumoto; Atsuto Hiyama; Goji Miura; Nobuyuki Tanaka; Takuya Emoto; Takeo Kawamura; Naofumi Matsunaga
Journal:  Eur Radiol       Date:  2003-05-21       Impact factor: 5.315

7.  Increased survival of children with solid tumours: how did we get there and how to keep the success going?

Authors:  Catherine Rechnitzer
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

8.  Abscess mimicking lung metastasis in a 10-year-old boy - case report.

Authors:  Danuta Roik; Tomasz Mosior; Barbara Sopyło; Jadwiga Małdyk; Michał Brzewski
Journal:  Pol J Radiol       Date:  2010-10

9.  Suitability of imaging methods (X-ray, CT, MRI) in the diagnostics of Ewing's sarcoma in children - analysis of own material.

Authors:  Elżbieta Kuleta-Bosak; Ewa Kluczewska; Joanna Machnik-Broncel; Wojciech Madziara; Monika Ciupińska-Kajor; Dorota Sojka; Wojciech Rogala; Jan Juszczyk; Robert Wilk
Journal:  Pol J Radiol       Date:  2010-01

10.  CORR Insights®: How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?

Authors:  Lauren W Averill
Journal:  Clin Orthop Relat Res       Date:  2021-02-01       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.